Encephalopathy at admission predicts adverse outcomes in patients with SARS‐CoV‐2 infection is a research paper published in CNS Neuroscience & Therapeutics (2021). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Hunan Natural Science Foundation under Award
Grant: GR399196
Hunan Natural Science Foundation under Award
Grant: 2018JJ3709
National Natural Science Foundation of China grant under Award
Grant: 81971696
National Cancer Institute (NCI) of the National Institutes of Health under Award
Grant: R03CA249554
National Natural Science Foundation of China grant under Award
Grant: 8181101287
National Institutes of Health
Grant: 7R03CA249554-03
Deep learning characterization of renal tumors
Research Scholar Grant by RSNA Research & Education Foundation
Amazon Web Service for the COVID-19 Diagnostic Development Initiative
Research Scholar Grant by RSNA Research & Education Foundation
Amazon Web Service for the COVID-19 Diagnostic Development Initiative
FWCI
0.41
Citation Percentile
0.6%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals